+Search query
-Structure paper
Title | Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 65, Page 12626-12638, Year 2022 |
Publish date | May 3, 2022 (structure data deposition date) |
Authors | Zetterberg, F.R. / MacKinnon, A. / Brimert, T. / Gravelle, L. / Johnsson, R.E. / Kahl-Knutson, B. / Leffler, H. / Nilsson, U.J. / Pedersen, A. / Peterson, K. ...Zetterberg, F.R. / MacKinnon, A. / Brimert, T. / Gravelle, L. / Johnsson, R.E. / Kahl-Knutson, B. / Leffler, H. / Nilsson, U.J. / Pedersen, A. / Peterson, K. / Roper, J.A. / Schambye, H. / Slack, R.J. / Tantawi, S. |
External links | J. Med. Chem. / PubMed:36154172 |
Methods | X-ray diffraction |
Resolution | 1.05 Å |
Structure data | PDB-7zqx: |
Chemicals | ChemComp-GOL: ChemComp-SCN: ChemComp-CL: ChemComp-JU0: ChemComp-MOH: ChemComp-HOH: |
Source |
|
Keywords | SUGAR BINDING PROTEIN / Inhibitor / complex |